Arexvy is a brand-name respiratory syncytial virus (RSV) vaccine. It’s used in some adults to help prevent lung disease from RSV. Arexvy should not be used during pregnancy and breastfeeding ...

The UAB-SCIMS offers a series of Fact Sheets on selected topics related to SCI. Some Fact Sheets are products of the University of Alabama at Birmingham Spinal Cord Injury Model System (UAB-SCIMS).

To bring physicians the best research at the intersection of biomedical science and clinical practice and to present the information in an understandable and clinically useful format. NEJM leads ...

Today, an overwhelming majority of Americans get news at least sometimes from digital devices. This fact sheet looks at the platforms Americans turn to for news, including patterns and trends. A large ...

Wednesday, GSK plc (NYSE:GSK) released topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of Arexvy (Respiratory Syncytial ...

The IRS, in a fact sheet released Thursday, reminded taxpayers that crowdfunding distributions may be includible in the gross income of the person receiving them, depending on the distributions' facts ...

Findings showed a noninferior immune response for both vaccines when coadministered compared with separate administration. Topline results were announced from a phase 3 study assessing the immune ...

GSK plc GSK announced positive topline results from a phase III study evaluating the co-administration of its two marketed vaccines — RSV vaccine Arexvy and shingles vaccine Shingrix — in ...